Skip to main content
Premium Trial:

Request an Annual Quote

Jackson Laboratory, Seven Bridges to Build PDX Data Platform With $2M NCI Grant

CHICAGO (GenomeWeb) – The Jackson Laboratory and biomedical data analysis technology vendor Seven Bridges are teaming up to build a platform for coordinating research with patient-derived tumor xenograft data sets. The National Cancer Institute is funding the effort with a $2 million grant.

Jax and Seven Bridges will establish and host what NCI has dubbed the PDX Data Commons and Coordinating Center in hopes of accelerating PDX-based translational research. The Data Commons and Coordinating Center will support a wider NCI project called PDXNet, a planned network to coordinate wide-scale PDX testing for preclinical cancer drugs.

The two partners said they would apply cloud computing and bioinformatics technologies to organize analysis of PDX studies underway at NCI and other research institutions, such as Washington University, the University of Utah, Baylor College of Medicine, MD Anderson Cancer Center, and the Wistar Institute. They also will seek to build interoperability between PDXNet and other major NCI datasets in the Seven Bridges-developed Cancer Genomic Cloud, including the Cancer Genome Atlas, Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and the Cancer Imaging Archive.

"Translational cancer research generates vast amounts of data that need to be stored and analyzed, and PDX trials represent one of the best preclinical platforms we have to realize the potential presented by precision oncology," Seven Bridges CEO Brandi Davis-Dusenbery said in a statement. "Making this data easily accessible to researchers is imperative to improving outcomes for cancer patients."

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.